Global Pharmaceutical Grade Lactose Market valued approximately USD 170.2 million in 2017 is anticipated to grow with a healthy growth rate of more than 4.4% over the forecast period 2018-2025.

The Pharmaceutical Grade Lactose market is developing and expanding at a significant pace. The Pharmaceutical Grade lactose is a specific grade of lactose which meets the unbending pharmaceutical prospects. The Pharmaceutical Grade Lactose is composed by concentrating whey or permeates to over-saturate the lactose that is further refined , dried and processed precisely & in a pre-defined manner. The Pharmaceutical grade lactose is made in many customized & specialty ranges to utilize in various (OSDFs)oral solid dosage forms such as dry powder inhalers, sachets, containers and tablets. The lactose could either be in a formless sate or in a crystalline state when in the solid form. In the present scenario, the most common type of crystalline lactose mainly includes a-Lactose monohydrate and B-lactose. The Pharmaceutical Grade lactose market is mainly driven owing to escalating support and approval from the various central government bodies to use pharmaceutical grade lactose as an excipient. As indicated by the 2017, in active ingredient database by the Food & Drug Administration, lactose is considered to be utilized as an excipient for various forms of dosage. In the present scenario, owing to expansive accessibility along with cost adequacy, lactose is constantly being adopted around the world. Moreover, the drug formulation combined with nanotechnology, proficient similarity with active ingredients & different excipients along with rising interest for dry powder inhalers would also pave the development and growth of pharmaceutical grade lactose market on the global scenario.

The regional analysis of Global Pharmaceutical Grade Lactose Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:

  • Crystalline Monohydrate Lactose
  • Inhalation Lactose
  • Granulated Lactose
  • Spray Dried Lactose

By Application:

  • Tablets Manufacturing
  • Capsule Manufacturing

By Regions:

  • North America

o U.S.
o Canada

  • Europe

o UK
o Germany

  • Asia Pacific

o China
o India
o Japan

  • Latin America

o Brazil
o Mexico

  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

The leading Market players mainly include-

  • Merck KGaA
  • Kerry Inc
  • DFE Pharma
  • Meggle
  • Armor Pharma
  • Alpavit
  • Bayer AG
  • Novartis AG
  • Sigma-Aldrich PLC
  • Abbott Laboratories
  • Astrazeneca PLC

Target Audience of the Global Pharmaceutical Grade Lactose Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors